At face value but they did say
FY21 NPAT guidance in the range of $400m-$430m, subject to market conditions
Thats another ~30% lower on FY21. Will be downgraded from everywhere I assume for now.
Currently trading at ~20 p/e on FY21 estimates based on report - way too expensive for a company thats shrinking. All imo.
Things may improve in future but for now thats what they reported,